In The News
Class action firm breaches costs disclosure rules again, fights penalty
Court won’t suppress name of barrister accused of sexual harassment
Firm in push for solicitors’ CFO in Philips class action, despite uncertainty
Class action against KPMG, Phoslock shouldn’t wait for rival case, court told
Deputy PM Marles sued by chief of staff who complained about bullying
Pacific Werribee centre owners get preliminary trial in $200M defects spat
Angus & Julia Stone’s claims against management company sent to UK
Albanese government dumps misinformation bill
Katy Perry wins appeal in trade mark fight with Aussie designer
Lawyers in NSW can’t use AI to generate affidavits, witness statements, court says
Please login to bookmarkClose

Two law firms that filed competing class actions against regenerative medicine company Mesoblast for allegedly misleading shareholders about its Remestemcel-L treatment for COVID-19 complications have agreed to join forces and sidestep a beauty parade.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au